These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11689220)

  • 1. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G; Bolla MK; Thorsson B; Sigurdsson G; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Nov; 159(1):187-92. PubMed ID: 11689220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.
    Corella D; Sáiz C; Guillén M; Portolés O; Mulet F; González JI; Ordovás JM
    Atherosclerosis; 2000 Oct; 152(2):367-76. PubMed ID: 10998464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.
    Gudnason V; Kakko S; Nicaud V; Savolainen MJ; Kesäniemi YA; Tahvanainen E; Humphries S
    Eur J Clin Invest; 1999 Feb; 29(2):116-28. PubMed ID: 10092998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T; Vohl MC; Houde I; Lachance JG; Noël R; Després JP; Douville P; Bergeron J
    Nephron; 2000 Apr; 84(4):333-41. PubMed ID: 10754410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.
    Klerkx AH; Tanck MW; Kastelein JJ; Molhuizen HO; Jukema JW; Zwinderman AH; Kuivenhoven JA
    Hum Mol Genet; 2003 Jan; 12(2):111-23. PubMed ID: 12499392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome.
    Vohl MC; Lamarche B; Pascot A; Leroux G; Prud'homme D; Bouchard C; Nadeau A; Després JP
    Int J Obes Relat Metab Disord; 1999 Sep; 23(9):918-25. PubMed ID: 10490796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.
    Cuchel M; Wolfe ML; deLemos AS; Rader DJ
    Atherosclerosis; 2002 Jul; 163(1):169-74. PubMed ID: 12048136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.
    Ikewaki K; Mabuchi H; Teramoto T; Yamada N; Oikawa S; Sasaki J; Takata K; Saito Y;
    Metabolism; 2003 Dec; 52(12):1564-70. PubMed ID: 14669156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
    Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.